Chapter 31: Blood Flow Dynamics & Circulatory Function

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome to the Deep Dive, the show engineered to take your most complex source material and extract the highest yield nuggets, giving you the shortcut to being truly well informed.

Today our Deep Dive is built entirely on chapter 31 of Ganong's review of medical physiology.

Our mission is to give you that crystal clear structure,

you know, the cause and effect logic you need to really master this stuff.

That's right.

We're not just reading definitions, we're connecting the complex composition of blood to the physics that dictates how it all flows.

And when you look at the circulatory system, you are looking at more than just a pump and some pipes.

I mean, it is a highly complex closed network.

It really is.

Its job is just relentless, delivering oxygen and nutrients, sweeping up waste, regulating temperature and distributing hormones.

It's a system that has to be perfectly fluid while also, you know, being ready to form a life -saving clot at a moment's notice.

To really get it, you have to tackle two core pillars at the same time.

The first is the fluid itself,

the blood, and also the lymph.

The second pillar is physics,

the fluid dynamics,

pressure, resistance.

Basically, all the rules that explain how this fluid moves through this huge network of vessels.

It's the engineering of it that's so incredible.

As an initial hook, I think we have to highlight the design of the path itself, because not all the circuits are built the same way, are they?

Absolutely not.

And that's a key point.

When you look at the systemic circulation, the blood supplying, you know, all your body's tissues, it's structured with numerous different circuits arranged, and this is crucial in parallel.

So the brain gets its own supply, the kidneys get their own.

Exactly.

Your limbs get separate feeds, all branching off the aorta.

And why is that parallel design so fundamental?

It's all about resource allocation.

This structure lets you have huge variations in regional blood flow without really changing the total flow from the heart.

So you can send more blood where it's needed most.

Precisely.

If you start sprinting, your leg muscles can demand, say, a tenfold increase in blood flow, while flow to your gut is cut back.

Because they're in parallel, one change doesn't mess up the others.

It's just a highly efficient way to manage supply and demand.

And you contrast that with the pulmonary circulation, which is a single path.

All the blood has to go through the lungs in sequence.

A serial connection.

A serial connection.

And this whole dual system is driven by the heart, of course, but it's also helped by a few secondary forces you really need to know about.

Like what?

Well, think about the elastic recoil of the big arteries.

They stretch when the heart pumps, then snap back.

That snap helps push blood forward during diastole.

Okay.

Then you have the simple mechanical actions, like skeletal muscles squeezing the veins when you move, and the negative pressure in your chest when you breathe in the thoracic pump.

They all help keep things moving.

All right.

Let's unpack the liquid tissue itself.

Blood.

I think defining the volume is the first step, and the numbers are pretty impressive.

They really are.

The total circulating blood volume averages about 8 % of your total body weight.

8%.

So for a standard 70 -kilogram person, you're looking at roughly 5 ,600 milliliters of blood.

And remember, it's a suspension.

About 55 % of that is the fluid part, the plasma, and the other 45 % is all the cells.

And those cells, the red cells, white cells, platelets, they're all being churned out in this massive factory, the bone marrow.

The source material really emphasizes that this is not just some passive tissue.

That's right.

The adult bone marrow is one of the largest and most active organs in the body.

It rivals the liver in size and weight.

That's incredible.

And this production process is called

hematopoiesis.

The dynamics inside the marrow are really one of the most remarkable physiological processes.

And this brings us to what you call the activity paradox, which is a perfect example of cause and effect driven by lifespan.

It is.

If you look at the cells inside the marrow, which Ginon illustrates, about 75 % of them belong to the white cell producing series, the myeloid series.

Only about 25 % are maturing red cells.

Which immediately sounds completely wrong to anyone who's seen a blood smear.

That's just dominated by red cells.

So why is the factory dedicating three -quarters of its capacity to the white cell line?

The whole answer is turnover rate.

It's lifespan.

Red blood cells are built to last.

They circulate for about 120 days.

Okay.

Most white blood cells, though, have very short half -lives.

Sometimes just hours or maybe a few days.

So the marrow has to be constantly, rapidly replacing them.

That huge 75 % production capacity is just to keep up.

That just elegantly explains the whole thing.

So at the very, very beginning of this process, how does the body decide what kind of cell to make?

It all starts with the hematopoietic stem cells, or HSCs.

These are pluripotent cells, which means they can produce every single type of blood cell.

They're the self -renewing master cells.

Well, from there.

The HSCs then differentiate into what are called committed progenitor cells.

These are already sort of on a one -way path to becoming a specific line, a megakaryocyte, a lymphocyte, an erythrocyte.

And the power of these stem cells goes beyond just blood, doesn't it?

Absolutely.

The source material is clear on this.

We think of them as blood progenitors, but HSCs are also the origin for a lot of other essential cells that don't circulate, such as osteoclasts for remodeling bone, cupper cells, the macrophages in your liver, mast cells for allergic responses.

The potential is so powerful that they can completely repopulate a patient's bone marrow, which is the whole basis of bone marrow transplantation.

So let's transition to those formed elements out in the bloodstream.

We can start with the defenders, the white blood cells, or leukocytes.

Okay.

So the normal range we're looking for is about 4 ,000 to 11 ,000 cells per microliter, and we categorize them based on how they look and how they stain.

You've got the granulocytes.

Because they have granules in their cytoplasm.

Exactly.

That includes the neutrophils, eucidophils, and basophils.

And the neutrophils are the undisputed majority, usually 50 to 70 % of the total count.

Then the other main group, the mononuclear cells.

Right.

Those are the non -granular types.

You have lymphocytes, with their big round nuclei, and monocytes, which are large cells with a kind of kidney -shaped nucleus.

Functionally, this is your army.

It provides layered defenses against everything from parasites to viruses and tumors.

Next up, the smallest element, but maybe the most critical for stopping blood loss,

the platelets, or thrombocytes.

Platelets are very distinctive.

They're tiny, only two to four micrometers, packed with granules, and, this is important, they are a nucleate.

They're basically just cell fragments.

I see.

The normal count is around 300 ,000 per microliter, and they only last for about four days, which, again, explains why the bone marrow has to work so hard.

So if they aren't true cells, how does the body even make fragments like that?

They come from these incredibly large, multi -nucleated cells in the bone marrow, called megakaryocytes.

Okay.

Platelets are literally formed by these giant cells sticking little cytoplasmic arms out into the circulation and just pinching off small pieces.

And the spleen has a pretty important role here, acting as a kind of holding pin.

It does.

A big chunk of the platelet population, maybe 25 to 40 percent, is just stored in the spleen.

This is why if a patient has a splenectomy, the removal of the spleen, they often get a big jump in their platelet count, a condition called thrombocytosis.

That whole storage pool gets released.

And now to the star of the show, the red blood cells, or erythrocytes, built for one purpose.

Their specialization is absolute.

They're a nucleate in mammals, and have that classic biconcave disc shape about 7 .5 micrometers across.

The shape just maximizes surface area for gas exchange.

And the counts are enormous.

Just staggering.

About 5 .4 million per microliter for men, 4 .8 million for women.

So when a doctor runs a complete blood count, a CBC,

what are the key clinical metrics from these red cells that you absolutely need to know?

Ganon lists four key metrics you use to classify anemias.

First is the hematocrit, or HCK.

That's just the percentage of the blood volume that's taken up by red cells, usually around 47 % for men.

Second, the mean corpuscular volume, or MCV.

This tells you the average size of a single red cell.

It's vital.

Too large, they're called macrocytes.

Too small, microcytes.

And what about the metrics related to the cargo they carry, the hemoglobin?

Right.

That's the mean corpuscular hemoglobin, MCH, and more importantly, the mean corpuscular hemoglobin concentration, MCHC.

What's the difference?

MCHC measures the concentration of hemoglobin inside the cell, no matter its size.

If the MCHC is low, the cells are called hypochromic.

They look pale under a microscope because they don't have enough hemoglobin packed in, which you see in things like iron deficiency anemia.

We have to come back to the spleen because it's the quality control checkpoint for these red cells.

How does it know when a cell is old or abnormal?

The mechanism is just physical brilliance.

The spleen is a selective filter.

And the whole thing hinges on cell flexibility.

Flexibility.

As red cells age, their membranes get stiff.

To get through the spleen, they have to squeeze through these incredibly narrow slits in the venous sinuses.

If a cell can't deform and pass through, it gets trapped, destroyed, and recycled by macrophages.

It ensures only the young, efficient cells stay in circulation.

So let's zoom in on hemoglobin, the molecule that really defines the red cell's entire purpose.

It's a masterpiece of biochemistry.

It is.

It's a huge globular molecule with four subunits.

Each subunit has a hemoide attached to a globin polypeptide chain.

And in normal adult hemoglobin, that's hemoglobin A.

Or HbA, right.

The globin part is built from two alpha chains and two beta chains.

So we call it alpha - Oh, the heme part, the red pigment.

That's where the real action is.

The hemoide is an iron -containing porphyrin.

Critically, oxygen binds reversibly to the ferrous iron, the text FP plus, at the center of that ring.

And it has to stay in that ferrous state to work.

There's a specific modification of HbA that's become one of the most important long -term markers in all of clinical medicine.

You mean hemoglobin A3A1C?

Exactly.

Right.

This is a glycated form of hemoglobin, meaning a glucose molecule has attached itself to the beta chain.

And why is that so useful?

Because the amount of attachment is proportional to the plasma glucose concentration over the entire 120 -day life of that red cell.

So measuring HbA1C gives doctors a beautiful long -term average of how well a patient's diabetes has been controlled over the last two to three months.

Okay.

So oxygen binding is reversible, but it's also very tightly regulated.

What are the critical factors that fine -tune hemoglobin's affinity for oxygen?

The affinity is dynamically affected by three things.

The surrounding pH, the temperature, and the concentration of something called 2 -3 -bisphosphoglycerate or 2 -3 -BPG inside the red cell.

And how do they work?

Well, both 2 -3 -BPG and hydrogen ions, which determine pH, compete with oxygen for binding sites on the deoxygenated hemoglobin.

When they bind, they change the shape of the molecule.

And that shape change.

It decreases hemoglobin's affinity for oxygen, and this is essential.

A lower affinity means hemoglobin lets go of its oxygen more easily in tissues that are working, hard tissues that are warmer, more acidic, and have high 2 -3 -BPG levels.

It ensures oxygen gets delivered exactly where it's needed most.

We also have to talk about the abnormal forms.

What happens if that iron atom changes from ferrous, textafi -2 plus tori dollars, to ferric, texkishi -3 plus?

If the iron gets oxidized, usually by certain drugs or toxins, it forms methamoglobin.

It's dark, it's dusky, and it cannot carry oxygen.

Is there a defense against that?

Yes, thankfully.

The body has an enzyme system, NADH -methamoglobin reductase, that's constantly working to convert the iron back to the useful ferrous state.

If you're born without that system, you have a condition called hereditary methamoglobinemia.

And then there's the insidious threat of carbon monoxide.

Carbon monoxide is so dangerous because hemoglobin's affinity for it is hundreds of times higher than its affinity for oxygen.

So even a tiny amount of CO in the air can rapidly kick oxygen off the binding sites, which quickly leads to severe hypoxia.

Now let's look at a natural variant, fetal hemoglobin, or HbF.

Its structure is alpha -gamma.

Why are those gamma chains so critical for a developing fetus?

Fetal hemoglobin is a beautiful physiological adaptation.

The gamma chains make it so HbF binds 2 -glo -3 BPG

much less tightly than adult hemoglobin does.

And because it binds 2 -glo -3 BPG poorly.

It maintains a much higher affinity for oxygen at any given oxygen level.

This difference in affinity is what drives the efficient movement of oxygen from the mother's circulation across the placenta to the fetus.

The integrity of the red cell membrane is paramount, and defects there lead to diseases based on fragility.

What holds the cell together?

The shape and flexibility are maintained by a protein mesh work just under the membrane, mostly made of spectrum and anchoring.

In hereditary spherocytosis, you have mutations in these proteins.

The cells become round and rigid spherocytes.

And that rigidity is a death sentence in the spleen.

It is.

They can't squeeze through the filter so they get trapped and destroyed, causing a chronic hemolytic anemia.

This also increases their osmotic fragility.

They burst much more easily in hypotonic solutions.

What about metabolic defects like G6PD deficiency?

G6PD deficiency is the most common enzyme defect.

G6PD is needed to generate NADPH, which is the cell's main protection against oxidative damage.

Without it, the red cell is extremely vulnerable to hemolysis when exposed to certain drugs or infections that cause oxidative stress.

And finally, we get to the hemoglobinopathies diseases of the globin chain itself, with sickle cell anemia as the classic example.

Sickle cell anemia is caused by hemoglobin S, or HBS, and it comes from a single, precise amino acid substitution, avaline, where a glutamic acid should be on the beta chain.

Just one amino acid.

Just one.

And the problem is that at low oxygen levels, like in the tissues, these HBS molecules start to polymerize, linking up into long, rigid fibers.

And what's the mechanical result of that polymerization?

It forces the red cell to deform into that characteristic rigid sickle shape.

This causes two huge problems.

One, the cells are destroyed rapidly, causing hemolysis.

And two, their stiffness makes them block small blood vessels, leading to these incredibly painful vaso -occlusive crises and organ damage.

It's a devastating disease, but the gene is still quite common.

That suggests a powerful evolutionary reason.

The persistence of the HBS gene is the classic example of heterozygous advantage.

If you carry one normal gene and one HBS gene, the sickle cell trait, you are significantly resistant to the deadliest form of malaria.

In malaria regions, that survival advantage is huge.

And modern treatments often try to hijack the body's own developmental pathways.

They do.

The standard drug, hydroxyurea, works by stimulating the production of fetal hemoglobin, HPF, in adults.

Because the chemochains are different.

Exactly.

HPF doesn't participate in the polymerization with HBS, nearly as well as adult hemoglobin does.

So increasing the amount of HPF in the cells effectively dilutes the sickling tendency and reduces the severity of the disease.

All right, let's pivot to the fluid medium itself, starting with a really crucial distinction.

Plasma versus serum.

This is a point that trips people up all the time.

Plasma is the fluid portion of blood before it is clotted, so it contains everything, including all the soluble clotting proteins like fibrinogen.

And serum.

Serum is what's left over after the blood is clotted and you remove the clot.

So what's missing from the serum then?

It's missing fibrinogen, which is now in the clot, and a few other clotting factors that got used, up factors two, V, and eight.

Interestingly, serum has a higher serotonin level because platelets release it during the clotting process.

Okay, focusing on those plasma proteins, albumin, globulin, fibrinogen, they do a lot more than just clot.

Their functions are critical.

Maybe the most important is maintaining fluid balance by exerting what's called oncotic pressure.

It's about 25 millimeter -beat Hg across the capillary wall.

And that's the pulling force.

That's the constant inward pulling force that draws water into the blood vessels.

It's what keeps the plasma volume up.

And what else?

Well, they also provide about 15 % of the blood's buffering capacity for pH, and many of them act as specific carriers for hormones, vitamins, drugs, things that need a chaperone to travel in the blood.

Most are made in the liver, except for antibodies, which come from lymphocytes.

When that protein balance goes wrong, you get hypoproteinemia.

Right, low plasma protein.

It can be from starvation, liver disease, or kidney problems where you're losing albumin in the urine.

But the single most important consequence, the critical cause and effect here, is severe edema.

Why does low protein cause all that swelling?

Because if you have fewer plasma proteins, you have lower plasma oncotic pressure.

There's less inward pulling force to draw fluid back into the capillaries from the tissues.

So the fluid just accumulates out there in the interstitial space, leading to swelling.

And speaking of that interstitial fluid, let's talk about lymph, the body's drainage system.

Lymph is simply tissue fluid that has entered the lymphatic vessels.

It's basically a plasma filtrate, so it have clotting factors and can clot.

But its protein concentration is always lower than plasmas.

Two critical return pathways.

First, it's essential for absorbing fats from the intestine.

And second, and this is crucial for fluid balance, it's the main way the body collects and returns the big plasma proteins and excess fluid that inevitably leak out of the capillaries back into the blood.

Without it, we'd all have terrible edema.

Now let's get into blood typing.

This is a topic where biochemistry is literally life or death.

The whole system is based on antigens on the red cell membranes.

We focus on the ABO system.

And the A and B antigens aren't proteins.

They're complex sugar chains oligosaccharides sticking off the cell surface.

What you have is determined by the enzyme you inherit.

So what's the molecular difference between type A and type B?

Everybody starts with the basic sugar structure called the H antigen.

If you're type A, you have an enzyme that adds a specific sugar, an acetylgalactosamine, to the end of that H antigen.

If you're type B, you have a different enzyme that adds a different sugar, galactose.

Type AB people have both enzymes.

And type O people have either functional enzymes.

So the H antigen is just left unchanged.

It's amazing that such a critical identity is determined by just a single terminal sugar molecule.

It is.

Now the flip side is the agglutinins, the antibodies in the plasma.

And a key point here is that these antibodies, anti or centib, develop naturally in infancies.

You don't need a transfusion.

They form in response to similar antigens on common gut bacteria and in food.

So the body learns to make antibodies against the blood type antigens it doesn't have.

A type A person has A antigens, so they'll have anti -B antibodies.

A type O person has neither antigens, so they'll have both anti -A and anti -B antibodies.

And when you mix incompatible blood, the antibodies bind to the antigens and cause that visible clumping or agglutination.

Which leads directly to the danger of hemolytic transfusion reactions.

These reactions happen when the recipient's antibodies attack the donor's red cells.

This causes rapid agglutination and massive cell destruction hemolysis.

And the consequences are severe.

Catastrophic.

You get a huge release of free hemoglobin into the plasma, which can overwhelm the kidneys and cause acute renal failure.

And this is the logic behind the universal donor and recipient labels.

Right.

Type AB people are universal recipients, because they don't have anti -A or anti -B antibodies to attack donor cells.

Type O are universal donors, because their cells don't have A or B antigens to be attacked.

But you still have to cross -match.

You always have to cross -match.

The book is very clear on that.

There are dozens of other blood group systems that can still cause problems.

The RH group is the second most important system.

What's the key difference between RH and ABO antibody development?

The RH system is defined by the D antigen.

If you have it, you're RH positive.

The crucial difference is this.

Unlike ABO, anti -D antibodies do not develop spontaneously.

An RH negative person has to be actively sensitized.

They need a prior exposure to RH positive cells.

Either through a transfusion or pregnancy.

Or pregnancy.

And that leads directly to the mechanism of hemolytic disease of the newborn, or erythroblastosis fatalis.

Walk us through that classic scenario.

Okay, you have an RH negative mother carrying an RH positive fetus.

During the first delivery, a little bit of the baby's blood often leaks into the mother's circulation.

This exposure sensitizes her, and she starts making anti -RH antibodies after the baby's born.

So it's the next RH positive pregnancy that's in danger.

Exactly.

In the subsequent pregnancy, those maternal anti -RH antibodies, which are a type that can cross the placenta, get into the fetal circulation and just start destroying the fetus's red blood cells.

And the consequences for the fetus are dire?

They are.

Severe hemolysis can lead to extreme edema, called hydrox fatalis,

or critically, kernicteris.

Can you explain kernicteris for us?

Kernicteris is a neurological syndrome.

The massive red cell destruction releases huge amounts of unconjugated bilirubin.

The newborn's liver isn't mature enough to process it, and it deposits in the basal ganglia of the infant's brain, causing permanent damage.

But prevention is one of the great triumphs of modern medicine.

How does RH immune globulin work?

It's highly effective.

It's a passive immunization.

If an unsensitized RH -negative woman delivers an RH -positive baby, she gets a shot of RH immune globulin.

This shot contains ready -made anti -RH antibodies.

I see.

These antibodies find and destroy any fetal RH -positive cells that got into her system before her own immune system has a chance to see them and make its own permanent antibodies.

It prevents the sensitization from ever happening.

Let's move to probably the most complex and delicately balanced system yet, hemostasis.

This is stopping blood loss, and it's an act of exquisite balancing.

It really is.

You're constantly trying to prevent bleeding out, while also preventing inappropriate clotting.

The moment a vessel is injured, the response is immediate and sequential.

First, vessel constriction, driven by serotonin and other things released by platelets.

Second, a quick, temporary platelet plug forms as platelets stick to the exposed collagen at the injury site.

And the third step makes that plug permanent.

That's the conversion to the definitive clot, and this requires the whole clotting cascade, which ultimately produces fibrin, to stabilize that plug.

So let's walk through that core transformation.

It starts with a soluble protein, fibrinogen.

The fundamental reaction is cleaving that soluble plasma protein, fibrinogen, into insoluble fibrin monomers.

These monomers then spontaneously link up into a loose mesh.

But that's not the final step.

No, that loose mesh has to be stabilized with covalent cross -links, a process catalyzed by activated factor 13 and calcium.

And the master catalyst for this whole process is thrombin.

Thrombin is the enzyme that cuts fibrinogen into fibrin.

It's formed from its inactive precursor, prothrombin, by activated factor X.

But thrombin does more than just cut.

It's a critical positive feedback signal.

It also activates platelets, endothelial cells, and even upstream clotting factors to rapidly amplify the whole cascade.

So activated factor X is the point where everything comes together, but it has two very different routes to get there, the intrinsic and extrinsic pathways.

Right.

The extrinsic pathway is your fast emergency response system.

Okay.

It's triggered when tissue thromboplastin, or TPL, is released from damaged tissue outside the vessel.

Okay.

TPL directly activates factor seven, and that complex then very quickly activates factor X.

It's the fast track.

And the intrinsic pathway.

The intrinsic pathway is activated by internal contact when factor 12 touches exposed collagen under the endothelium, or a foreign surface like glass.

It's a longer, more sequential cascade of activations, 12 to X to I to X, that ultimately also activates factor X.

Both pathways funnel into that same common pathway.

So if any of these factors are missing, you get bleeding disorders, like the classic example, hemophilia A.

Hemophilia A is a deficiency in factor eight, which is essential for that intrinsic pathway to work properly.

Another major one is von Willebrand, factor deficiency.

That molecule helps platelets stick to the injury and also carries factor eight around.

So if it's missing, you have a double whammy.

And what about the opposite problem, unwanted clotting or thrombotic disorders?

Thrombosis tends to happen when you have sluggish blood flow, which lets clotting factors accumulate, or when the vessel lining is damaged, like an atherosclerosis.

This is what leads to things like a pulmonary embolism.

And there are genetic risks that make some people more prone to clotting, right?

Yes, a congenital absence of protein C can lead to uncontrolled coagulation.

Even more common is a mutation in factor V, called factor V Leiden, which makes it resisted to being shut off by activated protein C.

The clotting system turns on, but the off switch is broken.

And then there's that terrifying emergency condition, disseminated intravascular coagulation, or DIC.

DIC is a catastrophic failure of the whole system, often triggered by severe sepsis or trauma.

You get widespread micro -clotting all over the body, which rapidly uses up all your platelets and clotting factors.

You're clotting everywhere.

And at the same time, because you've consumed all your clotting resources, you start bleeding uncontrollably from everywhere else.

It's a paradoxical nightmare of simultaneous clotting and bleeding.

The complexity of that coagulation cascade means the body has to have equally robust checks and balances, or we'd all clot solid.

What are the key anti -clotting mechanisms?

There are layers of defense.

At the cellular level, it's a balance between thromboxane A2 from platelets, which promotes clotting, and prostacyclin from the healthy endothelium, which prevents it.

It's a local tug of war.

And in the plasma itself, the key inhibitor is antithrombin the third.

Right.

Antithrombin the third is a circulating inhibitor that blocks several active clotting factors, especially factor Zyia and thrombin.

And its action is hugely boosted by heparin, a substance found naturally in mast cells.

But the most elegant safety mechanism involves the endothelium itself actively shutting down coagulation.

How does the thromomodulin protein C system work?

This is a remarkable molecular switch.

Healthy endothelial cells have a receptor on their surface called thrombomoculin.

When thrombin, the master clotting enzyme, binds to it, its function completely flips.

Flips from what to what?

It's converted from a pro -coagulant into a potent anti -coagulant.

This new complex then activates circulating protein C.

And what does activated protein C do?

Activated protein C, along with its cofactor protein S, goes and inactivates factors V and VIII.

By taking out those key amplification factors, it effectively puts the brakes on the clotting cascade, limiting the clot's extension.

It's the body's internal emergency brake.

Once a clot has done its job, the body needs to get rid of it.

That process is fibronolysis.

Fibronolysis is all about the enzyme plasmin.

Plasmin is like a molecular Pac -Man that goes around chewing up fibrin and fibrinogen.

Plasmin itself is formed from an inactive precursor, plasminogen.

And what activates the plasminogen to become plasmin?

That's handled by tissue -type plasminogen activator, or TPA.

What's so clever is that the activation is localized right to the vessel wall, where plasminogen binds to endothelial cells.

This ensures you're dissolving the clot where it is, not just breaking down clots all over your body.

Which is why recombinant TPA is used as a clot buster drug for heart attacks and strokes.

Exactly.

Finally, how do we pharmacologically manipulate this system, say with a drug like warfarin?

Warfarin works by inhibiting the action of vitamin K.

Vitamin K is an essential cofactor for an enzyme in the liver that modifies several key clotting factors, 2, 7, IX, and X, and also the regulatory proteins C and S.

So no vitamin K action means?

It means those factors are produced in a non -functional form.

You're essentially reducing the overall clotting tendency of the blood.

Now we shift completely from the fluid to the pipes, the physical architecture of the vascular system, and the physics that govern flow.

Let's start with the endothelium, which is way more than just a lining.

The endothelium is not a passive wrap.

It's a massive, active, distributed organ.

The cells are constantly monitoring flow, stretch, and shear stress.

And in response, they secrete vasoactive substances to control vessel tone and health.

It's an active participant.

And beneath that is the vascular smooth muscle, which controls the diameter.

Its contraction is designed for sustained effort, isn't it?

It is.

It uses the myosin light chain mechanism, but it also has something called the latch bridge mechanism.

This lets the muscle sustain prolonged contractions, maintaining that baseline vascular tone with very little energy use.

And how does it relax to allow more flow?

Relaxation is often local.

Little sparks of calcium released from internal stores can activate potassium channels.

Potassium flows out, hyperpolarizing the cell, which shuts off the calcium influx channels and leads to relaxation and vasodilation.

So let's review the vessel types.

Moving out from the heart, the large arteries are very elastic.

Yes, the aorta and large arteries are full of elastic tissue.

They stretch during systole and then recoil during diastole, which helps maintain continuous forward flow.

But the arterioles are different.

Very different.

They have very little elastic tissue, but a huge amount of smooth muscle.

And we have to emphasize this.

They are the major site of peripheral resistance.

Because tiny changes in their diameter cause massive changes in flow.

Massive.

They are the body's master flow regulators.

After the arterioles, we hit the site of actual exchange, the capillaries.

Tiny vessels, walls, just one cell thick.

Blood cells literally have to squeeze through in single file.

And the source material highlights that capillary structure varies a lot depending on the job it has to do.

What are the three main types?

We classify them by how leaky they are.

Continuous capillaries are the least permeable.

You find them in muscle and critically in the brain where they form the blood -brain barrier.

Then you have fenestrated capillaries, which have little pores or windows in them.

You find these where you need high volume exchange, like in the kidneys and the gut.

And the most porous type.

Those are the discontinuous capillaries, or sinusoids, which you find in the liver.

They have actual physical gaps between the cells.

This lets large molecules, even plasma proteins, pass freely between the blood and the liver cells.

Finally, the growth of new vessels.

Angiogenesis.

Angiogenesis is the formation of new vessels from existing ones.

It's essential for wound healing.

But pathologically, it's what allows tumors to grow.

The key signal is vascular endothelial growth factor, or VEGF.

Which is why VEGF blockers are now a major tool in cancer therapy.

Exactly.

You starve the tumor of its blood supply.

Okay, let's get into the hard physics.

The entire flow system is governed by a relationship that's basically analogous to Ohm's law in an electrical circuit.

The analogy is perfect.

Flow equals the pressure difference divided by the resistance.

Blood always flows down a pressure gradient.

Resistance is just whatever opposes that flow.

And we can measure that flow non -invasively using things like the Doppler effect.

The Doppler flow meter is standard.

It bounces ultrasonic waves off the moving blood cells.

The frequency shift of the reflected waves tells you how fast the blood is moving.

It's incredibly useful.

Now let's talk about the quality of the flow itself.

Laminar versus turbulent.

Normal blood flow is laminar.

You can think of it as smooth layers like a river.

The fluid near the wall is slow and the fastest flow is right in the center.

It's quiet and efficient.

When does that orderly flow break down into turbulence?

It becomes turbulent when the velocity gets too high, usually at a branch point or a narrowing.

We predict this using the Reynolds number.

If the Reynolds number gets above about 3000, you're going to have turbulence.

And this turbulence is clinically very important.

It is.

It increases the risk of plaque formation.

And crucially, turbulence is noisy.

It creates the sounds you hear with a stethoscope over a narrowed artery and it creates the Korotkov sounds we use to measure blood pressure.

You mentioned the endothelium responds to flow.

Let's look at the force the blood exerts on the lining.

That's shear stress.

It's the tangential dragging force of the flowing blood on the vessel wall.

And it's not just friction.

It's a vital biological signal.

Changes in shear stress actually activate transcription factors inside the endothelial cells.

So the physical movement of the blood literally changes the genetic programming of the vessel wall.

This activation changes the expression of genes for things like growth factors, nitric oxide synthase, which makes the vasodilator nitric oxide, and adhesion molecules.

The physics of flow directly modifies the biology of the vessel.

Moving back to velocity, the speed of flow.

We know the total cross -sectional area changes massively throughout the system.

How does that affect velocity?

Velocity is always inversely proportional to the total cross -sectional area.

Velocity is highest in the single narrow aorta, but collectively, the millions of capillaries have a total cross -sectional area that's a thousand times bigger.

So the flow slows to a crawl.

It slows way down.

And that's essential.

It provides the time needed for all that nutrient and gas exchange to happen before the blood speeds up again in the veins.

Now for the single most powerful factor governing resistance, described by the Poiseuille -Hugin formula.

This is the physics concept that changes everything.

You cannot overstate this.

The formula shows that resistance is proportional to vessel length and fluid viscosity.

But the absolute dominant term is the inverse of the radius to the fourth power.

R is proportional to one over R to the fourth.

Explain that for us.

What does that 444 relationship really mean in practice?

It means the relationship is explosive.

If you have the radius of a small arteriole, the resistance doesn't double.

It increases 16 -fold.

Wow.

Conversely, if you double the radius, resistance drops to one sixteenth of its previous value.

This is why the smooth muscle in the arterioles gives the body such exquisite control over blood flow.

Speaking of fluid properties, let's talk viscosity.

Blood isn't like water.

No, it's about three to four times more viscous, mostly because of the red cells.

Higher hematocrit means higher viscosity.

But there's a weird exception in really small vessels.

It's called the Freus -Linguist effect.

In tiny vessels, the red cells tend to stream down the very center, leaving a layer of low viscosity plasma near the wall.

This actually reduces the overall resistance in the microcirculation.

There's also a pressure concept that explains why flow can stop in small vessels, even if the pressure isn't zero.

That's the critical closing pressure.

Small vessels are surrounded by tissue that exerts an external pressure.

If the pressure inside the vessel drops below that external pressure, the vessel just collapses and flow stops completely.

We also have to hit the law of Laplace, especially for understanding the mechanical stress on the vessel wall.

The law of Laplace says that the tension in the wall of a cylinder is proportional to the pressure times the radius, T equals P times R.

The key takeaway is that wall tension is directly proportional to the radius.

So why don't capillaries with their incredibly thin walls just burst?

Because of their tiny radius.

The tiny radius results in extremely low wall tension, which protects them.

The pathological side of this is a dilated heart.

A bigger radius means the heart muscle has to generate way more tension, more work just to produce the same pressure.

Let's wrap this section up by classifying the vessels based on their main job.

We have two main categories.

The arterioles and small arteries are the resistance vessels because they control flow via that powerful 44 -4 relationship.

And the veins.

The veins are the capacitance vessels.

Because their walls are thin and stretchy, they can hold a huge amount of blood.

They're the body's blood reservoir, holding over half of the total systemic blood volume at any given time.

Okay, as blood flows through the system, the pressure waveform changes dramatically.

Let's quickly define the key arterial pressure values.

We have systolic pressure, the peak pressure during ejection, around 120 millimeter Hg.

Diastolic pressure is the minimum, around 70 millimeter Hg.

The difference is the pulse pressure.

And the mean arterial pressure is roughly the diastolic plus one -third of the pulse pressure.

And the biggest pressure drop happens across the arterioles.

As you'd expect, that's where the resistance is.

All those measurements are taken at heart level.

But gravity has a huge measurable effect.

It does.

For every vertical centimeter away from the heart, the pressure changes by 0 .77 millimeter Hg.

So when you stand up, the pressure in the arteries in your feet increases by over 80 millimeter Hg while the pressure in your head drops.

The Bernoulli Principle gives us insight into what happens when a vessel narrows, like with an atherosclerotic plaque.

The Bernoulli Principle is about conservation of energy.

So total energy, kinetic energy from velocity, plus potential energy from pressure, is constant.

When a vessel narrows, the velocity has to increase to get the same amount of blood through.

So kinetic energy goes up.

Kinetic energy goes up.

To keep the total energy constant, the potential energy, the lateral distending pressure on the wall, has to go down.

This pressure drop actually helps keep the narrowed segment constricted.

We measure pressure non -invasively using a sigmomanometer.

How do those karate cough sounds relate back to the turbulence we were talking about?

When you inflate the cuff, you stop the flow.

As you slowly release the pressure,

the very first tapping sound you hear is the systolic pressure.

That's the point where blood just starts to spurt through the collapsed artery,

creating turbulence and sound.

And the diastolic.

As the pressure drops, the sounds get muffled and then disappear.

The point where they disappear is the diastolic pressure.

Once the cuff pressure is below diastolic, the flow is smooth and laminar again.

So it becomes quiet.

The sustained elevation of that pressure hypertension is a massive public health problem.

It is.

It's usually caused by chronically increased peripheral resistance.

The main long -term problem is that the left ventricle has to pump against this high pressure all the time.

This causes the heart muscle to get bigger, a condition called left ventricular hypertrophy.

Which sounds strong, but it's actually a huge vulnerability, isn't it?

A critical vulnerability.

The bigger muscle needs more oxygen, but the coronary arteries that supply it don't grow to match.

This makes any underlying coronary artery disease much more dangerous.

Plus, hypertension increases the risk of stroke, heart attack, and kidney disease.

Most cases are essential, meaning the cause is unknown.

But the secondary causes are really instructive about the underlying physiology.

They are.

You can have renal artery stenosis, which tricks the kidney into thinking blood pressure is low, so it releases renin.

You can have endocrine disorders.

And the monogenic forms are fascinating.

In little syndrome, a mutation makes the sodium channels in the kidney overactive, causing too much salt and water retention, which drives up the pressure.

And looking at the demographics, blood pressure isn't stable over a lifetime, is it?

Not at all.

It generally rises with age.

Cystolic pressure rises pretty continuously.

Diastolic pressure tends to peak in middle age, and then can actually fall because the arteries get stiffer.

This means the pulse pressure widens significantly in older adults.

Back to the capillaries, the exchange of fluid is governed by the famous Starling forces.

This is the ultimate balancing act between hydrostatic and osmotic pressure.

It is.

The net movement of fluid is determined by the balance of two opposing forces.

You have the hydrostatic pressure, the physical pushing out pressure, and the oncotic pressure, the protein -driven pulling in pressure.

How does that balance play out along the length of a typical capillary?

At the arterial end, the hydrostatic pressure is high, higher than the oncotic pressure.

So you get a net filtration of fluid out of the capillary into the tissues.

As the blood moves along, the hydrostatic pressure drops.

By the time it gets to the venular end, the oncotic pressure is now dominant, and you get a net reabsorption of fluid back into the capillary.

The total volume of this exchange is huge.

Massive.

About 24 liters of fluid are filtered out every day across all the body's capillaries.

About 85 % of that is reabsorbed directly, and the remaining 15 % is picked up by the lymphatics.

And when that Starling balance is disturbed, we get edema.

Edema is just the abnormal accumulation of that interstitial fluid.

The causes fall into four neat categories.

You can have increased filtration pressure like in heart failure.

You can have decreased oncotic pressure from liver disease.

You can have increased capillary permeability from inflammation.

Or, finally, you can have a blocked lymphatic system.

Lastly, let's talk about venous return, getting all that blood back to the heart from those capacitance vessels,

often fighting gravity.

Venous return needs help.

First is the thoracic pump.

When you breathe in, the negative pressure in your chest sucks blood toward the heart.

Second, the heartbeat itself creates a little suction in the atria as the ventricles contract.

And the mechanical aid that's so important when we exercise.

The muscle pump.

When your skeletal muscles contract, they squeeze the deep veins.

And because the veins have one -way valves, this compression forces the blood unidirectionally back toward the heart.

If you stand still for too long, that pump stops working and blood pools in your legs.

There is a unique danger with venous pressure in the head, especially when you're sitting up.

Right.

The large dural sinuses in the skull are rigid and can't collapse.

So when you're upright, gravity can cause the pressure inside them to become negative subatmospheric.

If one of those is injured during surgery, it can actually suck air into the circulation, causing a very dangerous air embolism.

And just a final summary of how the lymphatic circulation flows.

It's essential for returning that fluid and protein.

The flow is actively driven by peristaltic contractions of the lymphatic vessels themselves.

They have smooth muscle and valves.

This, plus the muscle pump and thoracic suction, returns a quarter to half of the body's total plasma protein back to the blood every single day.

This deep dive into circulatory physiology has shown us a system that is, you know, simultaneously complex in its makeup and really elegant in its physical laws.

If you take away three high ACL principles from this, they have to be these.

First, that crucial dynamic balance between coagulation and anticoagulation, where the healthy endothelium actually converts thrombin, the master clotting enzyme, from a procoagulant to an anticoagulant using the protein C system.

It's a perfect safety switch.

Second, the immense power of that 4 -V4E4 relationship in vascular resistance.

It shows you exactly why the arterioles are the body's master flow controllers, and why tiny changes in their radius have such explosive effects on pressure and flow.

And third, the starling forces.

They govern that fluid exchange across the vital capillary beds, making sure that enough fluid filters out to nourish the tissues, while also guaranteeing the vast majority is efficiently reabsorbed to prevent life -threatening edema.

And to leave you with a final thought to mull over.

We talked about the complexity of the ABO and RH systems, but remember, there are hundreds of other blood group systems, totaling over 500 billion possible phenotypes.

This incredible genetic polymorphism strongly suggests there's some profound, unknown selective advantage to maintaining all this molecular complexity.

An advantage that goes way beyond just the need for transfusion compatibility.

It makes you wonder what other essential undiscovered jobs those little molecular flags on your red cells might be doing.

It definitely gives you something to think about the next time you look at a drop of blood.

Thank you for joining us for this deep dive into the fascinating world of blood as a circulatory fluid and the physics of flow.

We'll see you next time.